[{"NetIncomeLoss_1_Q3_USD":-18320000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":6427000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":19.35,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1342.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":7000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":4690000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1244000.0,"AssetsCurrent_0_Q3_USD":194122000.0,"OtherNoncashIncomeExpense_3_Q3_USD":18000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":113762000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4244000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":191000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":9109000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":64000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":123040000.0,"CommonStocksIncludingAdditionalPaidInCapital_0_Q3_USD":333151000.0,"CommonStockSharesIssued_0_Q3_shares":32941000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":69004000.0,"Assets_0_Q3_USD":200317000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-104000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-83000.0,"ShareBasedCompensation_3_Q3_USD":7456000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2306000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":6427000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1208000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":19534000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":44000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ResearchAndDevelopmentExpense_3_Q3_USD":40168000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":13699000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":14.35,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":6066000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":808000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":114474000.0,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q3_USD":28000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"RestrictedCash_0_Q3_USD":500000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":186800000.0,"OtherAssetsCurrent_0_Q3_USD":659000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-52275000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-18403000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":117820000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":4234000.0,"Liabilities_0_Q3_USD":13095000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-104000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-83000.0,"OperatingLeaseLiability_0_Q3_USD":5044000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":10.12,"DepreciationAndAmortization_3_Q3_USD":723000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":13065000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4752000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":29608000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":32890000.0,"InterestReceivableCurrent_0_Q3_USD":125000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":13.55,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":1022000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1280000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-145973000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":77494000.0,"CommonStockSharesOutstanding_0_Q3_shares":32921000.0,"RestrictedCashNoncurrent_0_Q3_USD":500000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":2333000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":51000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":7456000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2782000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-46089000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1173000.0,"LiabilitiesCurrent_0_Q3_USD":8833000.0,"NonoperatingIncomeExpense_3_Q3_USD":991000.0,"NonoperatingIncomeExpense_1_Q3_USD":131000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":118320000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7298000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":191000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q3_USD":0.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":119.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":407000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"PrepaidInsurance_0_Q3_USD":1022000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":6000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":13740000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3389000.0,"NetIncomeLoss_3_Q3_USD":-52171000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1773.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":290000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4224.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":68960000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2269000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":71000.0,"OperatingIncomeLoss_3_Q3_USD":-53162000.0,"OperatingIncomeLoss_1_Q3_USD":-18451000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":107856000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":2000000.0,"InvestmentIncomeInterest_3_Q3_USD":938000.0,"InvestmentIncomeInterest_1_Q3_USD":122000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":20.28,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.6,"LiabilitiesAndStockholdersEquity_0_Q3_USD":200317000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":7456000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2782000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":27400000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":5722000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":810000.0,"OperatingExpenses_3_Q3_USD":53233000.0,"OperatingExpenses_1_Q3_USD":18451000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.76,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.56,"OtherLiabilitiesCurrent_0_Q3_USD":810000.0,"StockholdersEquity_0_Q3_USD":187222000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":169000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":293000.0,"ShortTermInvestments_0_Q3_USD":69004000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]